Background: Since intentional overdose with rivaroxaban is expected to lead to significant
coagulopathy and bleeding, prophylactic reversal has been suggested. We report a single …

Rivaroxaban is a novel oral selective potent direct factor Xa (FXa) inhibitor. It is approved for
prevention of stroke in non-valvular atrial fibrillation (1), prevention and treatment of venous …

Novel oral anticoagulants offer equivalent or improved therapeutic profiles compared with
warfarin, with less risk of bleeding, no interactions with food, and no need for routine …

Rivaroxaban is an orally active direct factor Xa inhibitor used to treat venous
thromboembolism with approved starting dose of 15 mg twice-daily. We present a case of an …

Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and
management of thromboembolic disease in comparison to their predecessors. DOACs …

Rivaroxaban, an oral anticoagulant, directly inhibits factor Xa (FXa). A 35-month-old boy was
brought to the emergency department 15 minutes after ingesting 200 mg of rivaroxaban (16 …

Conservative management of massive rivaroxaban overdose: A case report and literature review
- Ghodsi - 2021 - Clinical Case Reports - Wiley Online Library Skip to Article Content Skip to …

We describe a patient case in which rivaroxaban failed to maintain therapeutic
anticoagulation in a patient while also taking oxcarbazepine. A 28-year-old male presented …

Interventions: The patient was closely monitored. The phenprocoumon overdose was
treated by the administration of vitamin K and PCC. Outcomes: Despite the massive …